Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503) (STRIDE2)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02766465 |
|
Recruitment Status :
Recruiting
First Posted : May 9, 2016
Last Update Posted : September 12, 2019
|
Sponsor:
Medical College of Wisconsin
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Blood and Marrow Transplant Clinical Trials Network
Dana-Farber Cancer Institute
National Marrow Donor Program
Emory University
Information provided by (Responsible Party):
Medical College of Wisconsin
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2022 |
| Estimated Study Completion Date : | March 2023 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):